Cargando…
Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates
The human gonadotropin releasing hormone (GnRH-I) and its sea lamprey analogue GnRH-III specifically bind to GnRH receptors on cancer cells and can be used as targeting moieties for targeted tumor therapy. Considering that the selective release of drugs in cancer cells is of high relevance, we were...
Autores principales: | Schuster, Sabine, Juhász, Éva, Halmos, Gábor, Neundorf, Ines, Gennari, Cesare, Mező, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105102/ https://www.ncbi.nlm.nih.gov/pubmed/35563462 http://dx.doi.org/10.3390/ijms23095071 |
Ejemplares similares
-
Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
por: Schuster, Sabine, et al.
Publicado: (2018) -
Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
por: Schuster, Sabine, et al.
Publicado: (2018) -
Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems
por: Murányi, József, et al.
Publicado: (2019) -
Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers
por: Pethő, Lilla, et al.
Publicado: (2019) -
Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells
por: Lajkó, Eszter, et al.
Publicado: (2019)